BSE filing, NSE: GILADAFINS. Summary written from the filing by ALFA Finder's alert engine.
Gilada Finance & Investments Ltd: key numbers
- Share price
- ₹11.69
- Market cap
- ₹16.42 Cr
- Revenue (annual)
- ₹7.26 Cr
- Net profit (annual)
- ₹2.17 Cr
- P/E (TTM)
- 7.9×Sector 19.7×
- Promoter holding
- 58.26%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Gilada Finance & Investments Ltd
All →Gilada Finance & Investments Annual General Meeting
Gilada Finance & Investments filed the summary of proceedings of its 32nd AGM held on 11 September 2026. Items included adopting audited financials, director re-appointment and an authorised capital increase.
Gilada Finance & Investments Annual Report
Gilada Finance & Investments Ltd has submitted its Annual Report and AGM Notice for the financial year 2025-26.
Gilada Finance & Investments Annual General Meeting
Gilada Finance and Investments Limited issued notice for its 32nd Annual General Meeting scheduled for September 11, 2026. Shareholders will consider business resolutions and capital increase.
Gilada Finance & Investments Q1 FY27 Results: Net Profit ₹0.5 Cr, Up 0.0% YoY
Gilada Finance & Investments Ltd reported revenue from operations of ₹1.8 Cr (+5.9% YoY) and net profit of ₹0.5 Cr (+0.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹0.5 Cr · +0.0% YoY
Gilada Finance & Investments Board Meeting Date
Gilada Finance & Investments Ltd schedules a board meeting on August 10, 2026, to consider financial results, the AGM notice, and NCD allotment.
Gilada Finance & Investments Other Announcement
The company submitted its quarterly shareholding pattern for the period ended June 30, 2026, as required under SEBI regulations.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.